Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Allez M, Mayer L. 2006. Regulatory T cells, peace keepers in the gut. Inflamm Bowel Dis. 10:666–676.
Baecher-Allan C, Hafler DA. 2004. Suppressor T cells in human disease. J Exp Med. 200:273–276.
Baecher-Allan C, Hafler DA. 2006. Human regulatory T cells and their role in autoimmune disease. Immunol Rev. 212:203–216.
Barnett Z, Larussa SH, Hogam M, Wei S, et al. 2004. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 64:8451–8455.
Battaglia M, Gregori S, Bacchetta R, Roncarolo MG. 2006. Tr 1 cells: From discovery to their clinical application. Semin Immunol. 18:120–127.
Beissert S, Schwarz A, Schwarz T. 2006. Regulatory T cells. J Invest Dermatol. 126:15–24.
Belkaid Y, Rouse BJ. 2005. Natural regulatory T cells in infectious disease. Nat Immunol. 6: 353–360.
Beyer M, Schultze JL. 2007. CD 4+CD25+high Foxp3+ regulatory T cells in peripheral blood are primarily of effector memory phenotype. J Clin Oncol. 25:2628–2630.
Bluestone JA, Abbas AK. 2003. Natural versus adaptive regulatory T cells. Nat Rev Immunol. 3:253–257.
Bluestone JA. 2004. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc Natl Acad Sci USA. 101:14622–14626.
Brimnes J, Allez M, Dotan I, Mayer L. 2005. Defects in CD8+ regulatory T cells in the Lamina Propria of patients with inflammatory bowel disease. J Immunol. 174:5814–5822.
Buckner JH, Ziegler SF. 2004. Regulating the immune system: The induction f regulatory T cells in periphery. Arthritis Res Ther. 6:215–222.
Cao D, Vollenhoven RV, Klareskog L, Trollmo C, Malstrom V. 2004. CD 25+CD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther. 6:R335–346.
Chatenoud L, Salomon B, Bluestone JA. 2001. Suppressor T cells – they’re back and critical for regulation of autoimmunity! Immunol. Rev. 182:149–163.
Chen Z, Benoist C, Mathis D. 2005. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci USA. 102:14735–14740.
Cohen IR, Quintana FJ, Mimran A. 2004. Tregs in T cell vaccination: Exploring the regulation of regulation. J Clin Inv. 114:1227–1232.
Dejaco C, Duftner C, Grubeck-Loebenstein B, Schrimer M. 2006. Imbalance of regulatory T cells in human autoimmune diseases. Immunology. 117:289–300.
Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. 2002. Human CD4+CD25+ regulatory, contact-dependent T cells induce interleukin 10 producing, contact-independent type 1-regulatory T cells. J Exp Med. 196:247–253.
Fehervari Z, Sakaguchi S. 2004. CD 4+ Tregs and immune control. J Clin Inv. 114:1209–1217.
Ferretti G, Felici A, Pino MS, Cognetti F. 2006. Does CTLA4 influence the suppressive effects of CD25+CD4+ regulatory T cells? J Clin Oncol. 24:5469–5470.
Fields RC, Bharat A, Mohanakumar T. 2006. The role of regulatory T-cells in transplantation tolerance. ASHI Quarterly. (first quarter):10–15.
Franzece O, Kennedy PTF, Gehring AJ, Gotto GM., et al. 2005. Modulation of the CD8+ T cell response by CD4+CD25+ regulatory T cells in patients with Hepatitis B virus infection. J Virol. 79:3322–3328.
Gershon RK, Kondo K. 1970. Cell interactions in the induction of tolerance: The role of thymic lymphocytes. Immunology. 18:723–737.
Gershon RK. 1975. A disquisition on suppressor T cells. Transplant Rev. 26:170–185.
Godfrey DI, Kronenberg M. 2004. Going both ways: Immune regulation via CD1d-dependent NKT cells. J Clin Inv. 114:1379–1388.
Gould HJ, Sutton BJ, et al. 2003. The biology of IgE and the basis of the allergic disease. Ann Rev Immunol. 21:579–628.
Green DR, Flood PM, Gershon RK. 1983. Immuno -regulatory T cell pathways. Ann Rev Immunol. 1:439–463.
Groux H. 2003. Type 1 T-regulatory cells: Their role in the control of immune response. Transplantation. 75:85–125.
Hawrylowicz CM, O’Garra A. 2005. Potential role of interleukin-10 secreting regulatory T cells in allergy and asthma. Nat Rev Immunol. 5:271–283.
Hong J, Zang YC, Nie H, Zhong J. 2006. CD 4+ regulatory T cell responses induced by T cell vaccination in patients with multiple sclerosis, PNAS. 103:5024–5029.
Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057–1061.
Ito T, Wang Y-H, Duramad O, Hanabuchi S, et al. 2006. OX 40 ligand shuts down IL-10 producing regulatory T cells. PNAS. 103:13188–13141.
Iwashiro M, Messer RJ, Peterson KE, Stronnes IM, et al. 2001. Immunosuppression of CD4+ regulatory T cells induced by chronic retroviral infection. PNAS. 98:9226–9230.
Janeway Jr. C. 1988. Do suppressor T cells exist? A reply. Scand J Immunol. 27:621–623.
Jerne NK. 1974. Towards a network theory of the immune system. Ann Immunol. 125:373–389.
Joosten SA, Meigjaarden KE, Savage N, Boer TD, et al. 2007. Identification of a human CD8+ regulatory T cells subset that mediates suppression through the chemokine CC chemokine ligand 4. PNAS, 104:8029–8034.
Karlsson MR, Rugtveit J, Brandtzaeg P. 2004. Allergen -responsive CD4+CD25+ regulatory T cells in children who have outgrown cow’s milk allergy. J Exp Med 12:1679–1688.
Kim JM, Rudensky A. 2006. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev. 212:86–98.
Knoechel B, Lohr J, Kahn E, Bluestone JA, Abbas AK. 2005. Sequential development of interleukin 2-depdent effector and regulatory T cells in response to endogenous systemic antigen. J Exp Med. 202:1375–1386.
Kretschmer K, Apostolou I, Jaechel E, Khazaie K., et al. 2006. Making regulatory T cells with defined antigen specificity: Role in autoimmunity and cancer. Immunol Rev. 212:163–169.
Latour RP, Dujardin HC, Mishellany F, Defranoux OB, et al. 2006. Ontogeny , function, and peripheral homeostasis of regulatory T cells in the absence of interleukin-7. Blood. 108: 2300–2306.
Liu H, Komai-Koma M, Xu D, Liew FY. 2005, Toll-like receptor2 signaling modulates the function of CD4+CD25+ regulatory T cells. PNAS. 103:7048–7053.
Lohr J, Knowchel B, Abbas AK. 2006. Regulatory T cells in periphery. Immunol Rev. 212: 149–162.
Lu L, Wermeck MBF, Cantor H. 2006. The immunoregulatory effects of Qα-1. Immunol Rev. 212:51–59.
Masteller EL, Tang Q, Bluestone JA. 2006. Antigen -specific regulatory T cells-ex vivo expansion and therapeutic potential. Semin Immunol. 18:103–110.
Nishizuka Y, Sakakura T. 1969. Thymus and reproduction: Sex linked dysgenesia of the gonad after neonatal thymectomy in mice. Science. 166:753–755.
O’Garra A, Vieira P. 2004. Regulatory T cells and mechanisms of immune system control. Nat Med. 10:801–805.
O’Garra A, Vieira P, Goldfeld A. 2004. IL -10 producing and naturally occurring CD4+ Tregs: Limiting collateral damage. J Clin Inv. 114:1372–1378.
Picca CC, Larkin III J, Boesteanu A, Lerman MA, Rankin AL, Caton AJ. 2006. Role of TCR specificity in CD4+CD25+ regulatory T cell selection. Immunol Rev. 212:74–85.
Qizhi T, Bluestone JA. 2006. Regulatory T cell physiology and application to treat autoimmunity. Immunol Rev. 212:217–237.
Reibke R, Garbi N, Hammerling GH, et al. 2006. CD 8+ regulatory T cells generated by neonatal recognition of peripheral self antigen. PNAS. 103:15142–15147.
Roncarlo MG, Gregori S, Battaglia M, Bacchetta R, et al. 2006. Interleukin -10 secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. 212:28–50.
Rouse BT, Sarangi PP, Suvas S. 2006. Regulatory T cells in virus infections. Immunol Rev. 212:272–286.
Sakaguchi S. 2004. Naturally arising CD4+ regulatory T cells for immunologic self tolerance and negative control of immune response. Ann Rev Immunol. 22:531–562.
Sakaguchi S. 2005. Naturally arising Foxp3-expressing Cd25+CD4+ regulatory T cells in immunological tolerance to self and nonself. Nat Immunol. 6:345–352.
Sakaguchi S. 2006. Regulatory T cells: Meden Agan, Immunological reviews, 212:1–5.
Sakaguchi S, Ono M, Setoguchi R, Yagi H, et al. 2006. Foxp 3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 212:8–27.
Sansom DM, Walker LS. 2006. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T cell biology. Immunol Rev. 212:131–148.
Schultze JL. 2006. Regulatory T cells: Timing is everything. Blood. 107:857.
Shevach EM. 2000. Regulatory T cells in autoimmunity. Ann Rev Immunol. 18:423–449.
Shevach EM. 2002. CD 4+CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol. 2:389–400.
Shevack EM. 2004. Fatal attraction: Tumors beckon regulatory T cells. Nat Med. 10:900–901.
Shevach EM, DiPaolo RA, Anderson J, Zhao DM. 2006. The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells. Immunol Rev. 212:60–73.
Snoeck V, Peters I, Cox E. 2006. The IgA system. Vet Res. 37:455–467.
Sutmuller RPM, den Brok HMGM, Kramer M, Bennink EJ, et al. 2006. Toll -like receptors control expansion and function of regulatory T cells. J Clin Invest. 116:485–494.
Taams LS, Palmer DB, Akbar AN, Robinson DS, et al. 2006. Regulatory T cells in human disease and their potential for therapeutic manipulation. Immunology. 118:1–9.
Tarbell KV. Yamazaki S, Steinman RM. 2006. The interaction of dendritic cells with antigen specific, regulatory T cells that suppress autoimmunity. Semin Immunol. 18:93–102.
Thomas D, Zaccone P, Cooke A. 2005. The role of regulatory T cell defects in Type I diabetes and the potential of these cells for therapy. Rev Diabet Stud. 2:9–18.
Umetsu DT, DeKruyff RH. 2006. The regulation of allergy and asthma. Immunol Rev. 212: 238–255.
Vigouroux S, Yvon E, Biagi E, Brenner MK. 2004. Antigen -induced regulatory T cells. Blood. 104:26–33.
Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK. 2003. Antigen -dependent proliferation of CD4+CD25+ regulatory T cells in vivo. J Exp Med. 198:249–258.
Walsh PT, Taylor DK, Turka LA. 2004. Tregs and transplantation tolerance. J Clin Inv. 114: 1398–1403.
Walsh PT, Buckler JL, Zhang J, Gelman AE, et al. 2006. PTEN inhibits IL-2 receptor mediated expansion of CD4+CD25+ Tregs. J Clin Inv. 116:2521–2531.
Wan YY, Flavell RA. 2006. The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol Rev. 212:114–130.
Wau Y, Flavell RA. 2007. Regulatory T cell functions are subverted and converted owing to attenuated FoxP-3 expression. Nature. 445:766–770.
You S, Thieblemont N, Alayankian MA, Bach J, Chatenoud L. 2006. Transforming growth factor-β and T-cell-mediated immunoregulation in the control of autoimmune diabetes. Immunol Rev. 212:185–202.
Zorn E, Nelson EA, Mohseni M, Porchery F, et al. 2006. IL -2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expression of these cells in vivo. Blood. 108:1571–1579.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Khan, M.M. (2008). Regulatory T Cells and Disease State. In: Immunopharmacology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-77976-8_9
Download citation
DOI: https://doi.org/10.1007/978-0-387-77976-8_9
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-77975-1
Online ISBN: 978-0-387-77976-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)